Shares of FibroGen jumped 5.08% to $19.96 at 12:13 EST on Tuesday, following last session’s downward trend. NASDAQ Composite is falling 0.86% to $13,794.72, following last session’s downward trend, This seems, at the moment, a somewhat negative trend exchanging session today.
FibroGen’s last close was $19.00, 186.62% under its 52-week high of $57.21.
The company’s growth estimates for the ongoing quarter and the next is 2.2% and 62.1%, respectively.
Year-on-year quarterly revenue growth grew by 715.1%, now sitting on 176.32M for the twelve trailing months.
FibroGen’s Stock Yearly Top and Bottom Value
FibroGen’s stock is valued at $19.96 at 12:13 EST, way below its 52-week high of $57.21 and above its 52-week low of $18.77.
FibroGen’s Moving Average
FibroGen’s value is way under its 50-day moving average of $39.14 and way below its 200-day moving average of $42.31.
More news about FibroGen.